1. Home
  2. ADIL vs SISI Comparison

ADIL vs SISI Comparison

Compare ADIL & SISI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADIL
  • SISI
  • Stock Information
  • Founded
  • ADIL 2010
  • SISI 1997
  • Country
  • ADIL United States
  • SISI China
  • Employees
  • ADIL N/A
  • SISI N/A
  • Industry
  • ADIL Biotechnology: Pharmaceutical Preparations
  • SISI Medicinal Chemicals and Botanical Products
  • Sector
  • ADIL Health Care
  • SISI Health Care
  • Exchange
  • ADIL Nasdaq
  • SISI Nasdaq
  • Market Cap
  • ADIL 6.5M
  • SISI 5.9M
  • IPO Year
  • ADIL 2018
  • SISI 2016
  • Fundamental
  • Price
  • ADIL $0.96
  • SISI $1.69
  • Analyst Decision
  • ADIL Strong Buy
  • SISI
  • Analyst Count
  • ADIL 1
  • SISI 0
  • Target Price
  • ADIL $8.00
  • SISI N/A
  • AVG Volume (30 Days)
  • ADIL 86.8K
  • SISI 617.5K
  • Earning Date
  • ADIL 11-13-2024
  • SISI 02-06-2025
  • Dividend Yield
  • ADIL N/A
  • SISI N/A
  • EPS Growth
  • ADIL N/A
  • SISI N/A
  • EPS
  • ADIL N/A
  • SISI N/A
  • Revenue
  • ADIL N/A
  • SISI $10,330,284.00
  • Revenue This Year
  • ADIL N/A
  • SISI N/A
  • Revenue Next Year
  • ADIL N/A
  • SISI N/A
  • P/E Ratio
  • ADIL N/A
  • SISI N/A
  • Revenue Growth
  • ADIL N/A
  • SISI 370.34
  • 52 Week Low
  • ADIL $0.77
  • SISI $1.63
  • 52 Week High
  • ADIL $4.17
  • SISI $117.65
  • Technical
  • Relative Strength Index (RSI)
  • ADIL 37.57
  • SISI 40.61
  • Support Level
  • ADIL $0.99
  • SISI $1.63
  • Resistance Level
  • ADIL $1.06
  • SISI $1.89
  • Average True Range (ATR)
  • ADIL 0.06
  • SISI 0.67
  • MACD
  • ADIL -0.01
  • SISI -0.06
  • Stochastic Oscillator
  • ADIL 0.00
  • SISI 1.58

About ADIL Adial Pharmaceuticals Inc

Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.

About SISI Shineco Inc.

Shineco Inc aims to care for a healthy life and improve the quality of life by providing safe, efficient, and high-quality health products and services to society. The company has researched and developed various vitro diagnostic reagents and related medical devices to date, and it also produces and sells healthy and nutritious food.

Share on Social Networks: